Replies to post #156519 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

The key for that two agent Stanford therapy to work is prior tumor infiltration by t-cells. The key to both DCVax products is they achieve tumor infiltration by t-cells. The problem with other immune therapies is they left t-cells at the tumor threshold. I think one researcher used to say they were knocking at the door. Anyway, one can easily see the opportunity for a tripartite study.

[jondoeuk]

They are using SD-101 produced by $DVAX and combining it with BMS 986178 (anti-OX40) given via IV infusion and low-dose radiation.